Allosterism in Drug Discovery
Although the concept of allosterism has been known for over half a century, its application in drug discovery has exploded in recent years. The emergence of novel technologies that enable molecular-level ligand-receptor interactions to be studied in studied in unprecedented detail has driven this trend. This book, written by the leaders in this young research area, describes the latest developments in allosterism for drug discovery.
Bringing together research in a diverse range of scientific disciplines, Allosterism in Drug Discovery is a key reference for academics and industrialists interested in understanding allosteric interactions. The book provides an in-depth review of research using small molecules as chemical probes and drug candidates that interact allosterically with proteins of relevance to life sciences and human disease. Knowledge of these interactions can then be applied in the discovery of the novel therapeutics of the future.
This book will be useful for people working in all disciplines associated with drug discovery in academia or industry, as well as postgraduate students who may be working in the design of allosteric modulators.
Allosterism in Drug Discovery, The Royal Society of Chemistry, 2016.
Download citation file:
Digital access
Print format
Table of contents
-
CHAPTER 1: Modulation of Biological Targets Using Allosteric Ligands: Food for Thoughtp1-23ByXinyan HuangXinyan HuangOffice of Therapeutics Alliances, New York University Langone Medical CenterOne Park Avenue, 6th FloorNew YorkNY 10016USASearch for other works by this author on:
-
CHAPTER 2: Identifying and Quantifying Allosteric Drug Functionp24-39ByTerry KenakinTerry KenakinDepartment of Pharmacology, University of North Carolina School of Medicine120 Mason Farm Road, Room 4042 Genetic Medicine Building, CB# 7365Chapel HillNC 27599USA[email protected]Search for other works by this author on:
-
CHAPTER 3: Targeting Catalytic and Non-Catalytic Functions of Protein Kinasesp40-64BySusanne Müller;Susanne MüllerNuffield Department of Clinical Medicine, University of Oxford, Structural Genomics ConsortiumOld Road Campus Research Building, Roosevelt DriveOxford OX3 7DQUKNuffield Department of Clinical Medicine, University of Oxford, Target Discovery Institute (TDI)Roosevelt DriveOxford OX3 7BNUKJohann Wolfgang Goethe-University, Institute for Pharmaceutical Chemistry and Buchmann Institute for Life SciencesMax-von-Laue-Str. 9D-60438 Frankfurt am MainGermany[email protected]Search for other works by this author on:Stefan KnappStefan KnappNuffield Department of Clinical Medicine, University of Oxford, Structural Genomics ConsortiumOld Road Campus Research Building, Roosevelt DriveOxford OX3 7DQUKNuffield Department of Clinical Medicine, University of Oxford, Target Discovery Institute (TDI)Roosevelt DriveOxford OX3 7BNUKJohann Wolfgang Goethe-University, Institute for Pharmaceutical Chemistry and Buchmann Institute for Life SciencesMax-von-Laue-Str. 9D-60438 Frankfurt am MainGermany[email protected]Search for other works by this author on:
-
CHAPTER 4: Molecular Biology Techniques Applied to GPCR Allosteric and Biased Ligandsp65-96ByArturo Mancini;Arturo ManciniDomain Therapeutics NA Inc.7171 rue Fréderick-BantingH4S 1Z9 St-Laurent (Montréal)CanadaSearch for other works by this author on:Billy Breton;Billy BretonDomain Therapeutics NA Inc.7171 rue Fréderick-BantingH4S 1Z9 St-Laurent (Montréal)CanadaSearch for other works by this author on:Stephan SchannStephan SchannSearch for other works by this author on:
-
CHAPTER 5: Examining Allosterism in a Dimeric G-Protein-Coupled Receptor Contextp97-130ByJesús Giraldo;Jesús GiraldoUniversitat Autònoma de Barcelona, Laboratory of Molecular Neuropharmacology and Bioinformatics, Institut de Neurociències and Unitat de Bioestadística08193 BellaterraSpain[email protected]Search for other works by this author on:Jordi Ortiz;Jordi OrtizUniversitat Autònoma de Barcelona, Laboratory of Molecular Neuropharmacology and Bioinformatics, Institut de Neurociències and Department of Biochemistry & Molecular Biology08193 BellaterraSpainSearch for other works by this author on:James Dalton;James DaltonUniversitat Autònoma de Barcelona, Laboratory of Molecular Neuropharmacology and Bioinformatics, Institut de Neurociències and Unitat de Bioestadística08193 BellaterraSpain[email protected]Search for other works by this author on:Bin ZhouBin ZhouUniversitat Autònoma de Barcelona, Laboratory of Molecular Neuropharmacology and Bioinformatics, Institut de Neurociències and Unitat de Bioestadística08193 BellaterraSpain[email protected]Search for other works by this author on:
-
CHAPTER 6: A Unifying Approach to the Duality of “Energetic” Versus “Conformational” Formulations of Allosteric Coupling: Mechanistic Implications for GPCR Allosteryp131-155ByTommaso CostaTommaso CostaSearch for other works by this author on:
-
CHAPTER 7: mGlu2 Receptor Positive Allosteric Modulatorsp156-174ByA. A. Trabanco;A. A. TrabancoNeuroscience Medicinal Chemistry, Janssen Research & Development, Janssen–Cilag SAC/Jarama 75AToledo45007Spain[email protected]Search for other works by this author on:J. M. Cid;J. M. CidNeuroscience Medicinal Chemistry, Janssen Research & Development, Janssen–Cilag SAC/Jarama 75AToledo45007Spain[email protected]Search for other works by this author on:G. TresadernG. TresadernDiscovery Sciences, Janssen Research & Development, Janssen–Cilag SAC/Jarama 75AToledo45007SpainSearch for other works by this author on:
-
CHAPTER 8: Muscarinic Receptors Allosteric Modulationp175-193ByBruce J. Melancon;Bruce J. MelanconDepartment of Chemistry and Biochemistry, Warren Family Research Center for Drug Discovery and Development, University of Notre DameNotre DameIN 46556USASearch for other works by this author on:Corey R. HopkinsCorey R. HopkinsDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical CenterOmahaNE68198 USA[email protected]Search for other works by this author on:
-
CHAPTER 9: Positive Allosteric Modulators of Opioid Receptorsp194-219ByAndrew AltAndrew AltSearch for other works by this author on:
-
CHAPTER 10: mGlu4 PET Ligands as Enablers of Target Biology Understandingp220-246ByZhaoda Zhang;Zhaoda ZhangAthinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital149, 13th Street, Suite 2301CharlestownMA 02129USA[email protected]Search for other works by this author on:Pekka Poutiainen;Pekka PoutiainenAthinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital149, 13th Street, Suite 2301CharlestownMA 02129USA[email protected]Search for other works by this author on:Anna-Liisa BrownellAnna-Liisa BrownellAthinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital149, 13th Street, Suite 2301CharlestownMA 02129USA[email protected]Search for other works by this author on:
-
CHAPTER 11: Allosteric Modulators of Adenosine, P2Y and P2X Receptorsp247-270ByKenneth A. Jacobson;Kenneth A. JacobsonMolecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of HealthBethesdaMD 20892USA[email protected]Search for other works by this author on:Zhan-Guo GaoZhan-Guo GaoMolecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of HealthBethesdaMD 20892USA[email protected]Search for other works by this author on:
-
CHAPTER 12: Positive Allosteric Modulators of G-Protein-Coupled Receptors that Act via Covalent Mechanisms of Action1p271-280ByWhitney M. Nolte;Whitney M. NolteWorldwide Medicinal Chemistry, Worldwide Research & Development, Pfizer Inc.610 Main StreetCambridgeMassachusetts02139USA[email protected]Search for other works by this author on:Philip A. CarpinoPhilip A. CarpinoWorldwide Medicinal Chemistry, Worldwide Research & Development, Pfizer Inc.610 Main StreetCambridgeMassachusetts02139USA[email protected]Search for other works by this author on:
-
CHAPTER 13: Mechanism of Action of a GluN2C- and GluN2D-Selective NMDA Receptor Positive Allosteric Modulatorp281-309ByKatie L. Strong;Katie L. StrongEmory University, Department of Pharmacology1510 Clifton RoadAtlantaGA30322USASearch for other works by this author on:Stephen F. Traynelis;Stephen F. TraynelisEmory University, Department of Pharmacology1510 Clifton RoadAtlantaGA30322USASearch for other works by this author on:Dennis C. LiottaDennis C. LiottaSearch for other works by this author on:
-
CHAPTER 14: Development of AMPA Receptor Modulators as Cognition Enhancersp310-333ByCraig Jamieson;Craig JamiesonDepartment of Pure and Applied Chemistry, University of Strathclyde295 Cathedral StreetGlasgow G1 1XLUK[email protected]Search for other works by this author on:Emma L. DuffyEmma L. DuffyDepartment of Pure and Applied Chemistry, University of Strathclyde295 Cathedral StreetGlasgow G1 1XLUK[email protected]Search for other works by this author on:
-
CHAPTER 15: Allosteric Modulation of Neuronal Nicotinic Acetylcholine Receptorsp334-359ByMark M. Levandoski;Mark M. LevandoskiDepartment of Chemistry and Programs in Biological Chemistry and NeuroscienceGrinnell CollegeGrinnellIA 50112USA[email protected]Search for other works by this author on:Sivaramakrishna KogantiSivaramakrishna KogantiDepartment of Chemistry and Programs in Biological Chemistry and NeuroscienceGrinnell CollegeGrinnellIA 50112USA[email protected]Search for other works by this author on:
-
CHAPTER 16: Allosteric Binding in the Serotonin Transporter – Pharmacology, Structure, Function and Potential Use as a Novel Drug Targetp360-380ByClaus J. Loland;Claus J. LolandDepartment of Neuroscience and Pharmacology, Faculty of Health and Medical Sciences, University of CopenhagenDK-2200 CopenhagenDenmarkSearch for other works by this author on:Connie Sanchez;Connie SanchezBrintellix Science Team, Lundbeck USA215 College RoadParamusNJ 07652USASearch for other works by this author on:Per Plenge;Per PlengeDepartment of Neuroscience and Pharmacology, Faculty of Health and Medical Sciences, University of CopenhagenDK-2200 CopenhagenDenmarkSearch for other works by this author on:Benny Bang-AndersenBenny Bang-AndersenSearch for other works by this author on:
-
CHAPTER 17: Allosteric Inhibition of Abl Kinasep381-403ByAnna Lucia Fallacara;Anna Lucia FallacaraDipartimento di Biotecnologie, Chimica e Farmacia, Università degli Studi di SienaVia Aldo Moro 253100 SienaItalySearch for other works by this author on:Silvia Schenone;Silvia SchenoneDipartimento di Farmacia, Università degli Studi di GenovaViale Benedetto XV, 316132 GenovaItalySearch for other works by this author on:Maurizio BottaMaurizio BottaDipartimento di Biotecnologie, Chimica e Farmacia, Università degli Studi di SienaVia Aldo Moro 253100 SienaItalySbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, BioLife Science BuildingSuite 333, 1900 N 12th StreetPhiladelphiaPennsylvania 19122US[email protected]Search for other works by this author on:
-
CHAPTER 18: Allosteric Modulators of Heat Shock Protein 90 (HSP90)p404-426ByYen Chin Koay;Yen Chin KoayUniversity of New South Wales, School of ChemistryKensingtonNSW 2052 Australia[email protected][email protected]Search for other works by this author on:Shelli McAlpineShelli McAlpineUniversity of New South Wales, School of ChemistryKensingtonNSW 2052 Australia[email protected][email protected]Search for other works by this author on:
Spotlight
Advertisement
Advertisement